Eli Lilly and Company
Identification

Nome strumento
ELI LILLY AND COMPANY
Ticker
LLY
Codice ISIN
US5324571083
Mercato
Euronext
Borsa
Paris
Products family
Stocks
ICB
Pharmaceuticals
Activity description
Eli Lilly and Company is one of the world’s leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- neurology (33.5%): primarily drugs used in treating depression and schizophrenia;
- endocrinology (30.1%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (14.5%);
- cardiovascular diseases (11.7%);
- veterinary medicine (9%);
- other (1.2%).
Net sales are distributed geographically as follows: the United States (54.5%), Europe (18.9%), Japan (9.9%) and other (16.7%).
Source: Cofisem
Indirizzo web
http://www.lilly.com
Operation
Data IPO
Lun 25/03/2013
Tipologia IPO
Direct listing
Categoria
IPO